Table 4. Extracorporeal life support (ECLS) characteristics.
| Variable | VA-ECMO (n=15) | VV-ECMO (n=13) | Total (n=28) | P value |
|---|---|---|---|---|
| ECLS support duration (days), median [IQR] | 9 [8–12] | 20 [11–28] | 12 [8–21] | 0.081 |
| Cannulation, n (%)* | 0.278 | |||
| Central | 2 (33.3) | 0 (0.0) | 2 (13.3) | |
| Peripheral | 4 (66.7) | 9 (100.0) | 13 (86.7) | |
| Additional/concomitant support, n (%) | ||||
| Intra-aortic balloon pump | 2 (13.3) | 0 (0.0) | 2 (7.1) | 0.528 |
| Impella | 1 (6.7) | 0 (0.0) | 1 (3.6) | 1.000 |
| Hemodialysis | 0 (0.0) | 4 (30.8) | 4 (14.3) | 0.075 |
| Additional/concomitant surgeries, n (%) | 3 (20.0) | 2 (15.4) | 5 (17.9) | 1.000 |
| Lung transplant | 0 (0.0) | 1 (7.7) | 1 (3.6) | 0.942 |
| RVAD surgery | 1 (6.7) | 0 (0.0) | 1 (3.6) | 1.000 |
| BiVAD surgery | 1 (6.7) | 0 (0.0) | 1 (3.6) | 1.000 |
| Colectomy | 1 (6.7) | 0 (0.0) | 1 (3.6) | 1.000 |
| Hemothorax evacuation | 0 (0.0) | 1 (7.7) | 1 (3.6) | 0.942 |
VA, veno-arterial; VV, veno-venous; ECMO, extracorporeal membrane oxygenation; IQR, interquartile range; RVAD, right ventricular assist device; BiVAD, biventricular assist device. *, provided for six patients in the VA-ECMO group, and nine patients in the VV-ECMO group.